Skip to main content
SpringerLink
Log in

Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Measles, which is still killing about two million children a year in poor countries, was mostly eliminated within two to three months after the conclusion of a special, national mass vaccination campaign in which all children of a selected age group received measles vaccine subcutaneously during a period of days to months, regardless of a history of previous vaccination or measles. This strategy was tested in the Dominican Republic in 1985, in Cuba in 1986–87, and in the State of São Paulo, Brazil May 11 – June 10, 1987. Subsequent control was maintained by different procedures in the three states.

A simple, rapid indirect immunoflueorescent test for IgM measles antibody, used in Greater São Paulo, was more efficient in confirming concurrent infection with measles virus than the hemagglutination inhibition test for IgG antibody, and only one blood specimen taken during the course of the rash was needed to confirm the etiologic diagnosis in 97.5% of 240 cases confirmed by IgM. In Greater São Paulo and Cuba, it was found that over 90% of the small number of suspect measles cases reported during the first year after the mass campaign, were not caused by measles virus.

The cost of disposable syringes and needles in the State of São Paulo, where 8,565,230 children were vaccinated in 10,527 centers in 30 days, was U.S. $2,057,753 or 63% of the total. Immunization by aerosol could have vaccinated this number of children more easily and effectively in one day if each of the vaccination centers had been supplied with one plastic foot or hand pressure pump and nebulizer at a cost of only about U.S. $300,000.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. AssaadF. (1983): Measles: Summary of worldwide impact. - Rev. Infect. Dis., 5: 452–459.

    Google Scholar 

  2. BritoG. de S., VranjacA. and Cássio de MoraesJ. (1988): Situação do programa de imunização e de controle das doenças preveneveis por vacinas no Estado de São Paulo e no Brasil. - Imunizações Atualização 1: 13–17.

    Google Scholar 

  3. CáceresM., ReyesD., TactukM. and MendozaH.R. (1986): La problematica de la infeccion sarampinosa en el Hospital de Niños Roberto Reid Cabral (H.R.R.C.) de Santo Domingo. Boletin Unidad de Estudios Especiales (H.R.R.C.), 1 (No. 2): 1–2.

    Google Scholar 

  4. Cássio de Moraes J., Pannuti C., Camargo M.C.C., Moura de Almeida M, Fick de Souza, VA. U., Hidalgo N.T.R., Brito G. de S. et al. (1988): Pesquisa sobre avaliação da cobertura vacinal contra o sarampo e a poliomielite, morbidade do sarampo e prevalencia de anticorpos antisarampo — Grande São Paulo, Janeiro de 1985 a Agosto de 1987. Document of preliminary data prepared for the Secretaria de Estado da Saúde de São Paulo.

  5. Centers for Disease Control (1989): Measles-Hungary. Morbidity and Mortality Weekly Report 38: 665–668.

    Google Scholar 

  6. Centers for Disease Control (1990): International task force for disease eradication. - Mordibity and Mortality Weekly Report 39: 209–212 and 217.

    Google Scholar 

  7. FoegeW.H. (1971): Measles vaccination in Africa. -PAHO Sc. Pub. 226: 207–212.

    Google Scholar 

  8. HendersonR.H. (1984): Vaccine preventable diseases of children: the problem. In: Protecting the world's children: vaccines and immunization — report of Bellagio Conference, March 13–15 1984. New York: Rockefeller Foundation, p. 9.

    Google Scholar 

  9. HinmanA.R., KirbyC.D., EddinsD.L., Orenstein, W.A., BernierR.H., TurnerP.M. and BarrtK.J. (1983): Elimination of indigenous measles from the United States. - Rev. Infect. Dis., 5: 538–545.

    Google Scholar 

  10. HullH.F., WilliamsP.J. and OldfieldF. (1983): Measles mortality and vaccine efficacy in rural West Africa. — Lancet 1: 972–975.

    Google Scholar 

  11. JohnT.J., JosephA., GeorgeT.I., RhadhakrishnanJ., SinghR.P.D. and GeorgeK. (1980): Epidemiology and prevention of measles in rural South India. - Indian J. Med. Res. 72: 153–158.

    Google Scholar 

  12. KrugmanS., KatzS.L., GershonA.A. and WilfertC. (1985): Infectious diseases of children. Eight Edition. The C.V. Mosby Company, St. Louis, Missouri, USA (see p., 154).

    Google Scholar 

  13. KrugmanR.D., WitteJ.J., ParkmanP.D., HerrmannK.L., MeyerH.M.Jr., WendeR.D., MeyerB.C. and DungcaR. (1977): Combined administration of measles, mumps, rubella and trivalent oral poliovirus vaccine. Combined vaccine studies. - Pub. Health Rep. 92: 220–222.

    Google Scholar 

  14. LievensA. W. and BrunellP.A. (1986): Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles. — J. Clin. Microbiol. 24: 391–394.

    Google Scholar 

  15. McAleerW.J., MarkusH.Z., McLeanA.A., BunyakE.B. and HillemanM.R. (1980): Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. — J. Biol. Standardization 8: 281–287.

    Google Scholar 

  16. McAleer W.J. and Markus H.Z. (1979): Vaccine stabilizer. - U.S. Patent Office no. 4,147,772.

  17. Mendoza H., Bautista L., Montero R. and Gonzales J. (1986): Sarampion en el Hospital de Niños Robert Reid Cabral y los effectos de la campaña de vacunacion del 1985. - Boletin Unidad de Estudios Especiales (H.R.R.C.), No. 3: 1–3.

  18. PAHO, EPI Newsletter (1990): 12: 7.

  19. PannutiC.S., Fick de SouzaV.A.U., TakaokaN., LemeS.T. da S., PereiraC.R., CarvalhoR.P. de S. and AmatoV., Neto (1987): Interferencia entre as vacinas antisarampo e antipoliomielite. - Bol. of. Sanit. Panam. 103: 227–232.

    Google Scholar 

  20. Parkman P.D., Hopps HE., Albrecht P. and Meyer H.M. Jr. (1983): Simultaneous administration of vaccines. - In Recent Advances in Immunization, edit. by Halsey N.A. and de Quadros C.A., PAHO Scientific Publication 451, 102: 65–80, Washington, D.C.

  21. RisiJ.B.Jr. (1984): The control of poliomyelitis in Brazil. - Rev. Infect. Dis., 6 (Suppl.): S400–403.

    Google Scholar 

  22. Rodriguez CruzR. (1984): Cuba: mass polio vaccination program; 1962–1982. - Rev. Infect. Dis., 6 (Suppl.): S408–412.

    Google Scholar 

  23. SabinA.B. (1983): Immunization against measles by aerosol. - Rev. Infect. Dis. 5: 514–523.

    Google Scholar 

  24. SabinA.B. (1984): Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine. - Rev. Infect. Dis., 6 (Suppl.): S391–396.

    Google Scholar 

  25. SabinA.B. (1986): Strategy for rapid elimination and continuing control of poliomyelitis and other vaccine preventable diseases of children in developing countries. - Brit. Med. J. 292: 531–533.

    Google Scholar 

  26. SabinA.B., MichaelsR.H., KrugmanS., EigerM.E., BermanP.H. and WarrenJ. (1963): Effect of oral poliovirus vaccine in newborn children. I. Excretion of virus after ingestion of large doses of type 1 or a mixture of all three types, in relation to level of placentally transmitted antibody. Pediatrics 31: 623–640.

    Google Scholar 

  27. SabinA.B., Flores ArechigaA., Fernandez de CastroJ., SeverJ.L., MaddenD.L., ShekarchiI. and AlbrechtP. (1983): Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccine. -J.A.M.A. 249: 2651–2662.

    Google Scholar 

  28. SabinA.B., Flores ArechigaA., Fernández de CastroJ., AlbrechtP., SeverJ.L. and ShekarchiI. (1984): Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. - J.A.M.A. 251: 2363–2371.

    Google Scholar 

  29. SabinA.B., AlbrechtP., TakedaA.K., RibeiroE.M. and VeronesiR. (1985): High effectiveness of chick embryo fibroplast measles vaccine in seven month-old and older infants. - J. Infect. Dis. 152: 1231–1237.

    Google Scholar 

  30. World Health Organization, EPI Update, April (1990).

  31. World Health Oganizatation, Weekly Epidemiological Record, 15 January (1988): No. 3, p. 11.

  32. WilliamsP.J. and HullH.F. (1983): Studies of measles in The Gambia (1981): Rev. Infect. Dis. 5: 391–394.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 3101 New Mexico Ave., N. W. - Apartment 1001, 20016-5902, Washington, D.C., U.S.A.

    A. B. Sabin

Authors
  1. A. B. Sabin
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The work reported here was begun in 1984 at the Fogarty International Center for Advanced Study in the Health Sciences, National Institutes of Health, Bethesda, Maryland, and, after retirement at age 80 in 1986, was continued at home and in the Dominican Republic, Cuba, and São Paulo, Brazil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sabin, A.B. Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control. Eur J Epidemiol 7, 1–22 (1991). https://doi.org/10.1007/BF00221337

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00221337

Key words

Search

Navigation